12 | Glucose (Dextrose)FDA LinkGeneric
09/2013
-
07/2002 |
9 | Hypoglycemic Agents (Hypoglycemics)IBA
04/2012
-
08/2006 |
9 | Vasopressins (Vasopressin)IBA
01/2012
-
01/2006 |
8 | Insulin (Novolin)FDA Link
09/2013
-
08/2006 |
6 | Streptozocin (Streptozotocin)FDA Link
07/2014
-
12/2008 |
5 | ipragliflozinIBA
07/2014
-
01/2012 |
5 | Niacinamide (Nicotinamide)FDA LinkGeneric
09/2013
-
12/2008 |
5 | 4- fluoro- 1- (((4- methyl- 1- (methylsulfonyl)piperidin- 4- yl)amino)acetyl)pyrrolidine- 2- carbonitrileIBA
03/2009
-
05/2008 |
4 | Dipeptidyl-Peptidase IV InhibitorsIBA
01/2014
-
07/2008 |
4 | YM 440IBA
11/2006
-
07/2002 |
3 | Sodium-Glucose Transport ProteinsIBA
07/2014
-
01/2012 |
3 | Blood Glucose (Blood Sugar)IBA
09/2013
-
02/2009 |
3 | Collagen Type IV (Type IV Collagen)IBA
01/2012
-
02/2008 |
3 | 4'- (4,4- difluoro- 5- (2- oxo- 2- (4- piperidinopiperidino)ethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- methyl- 3- furanilideIBA
06/2007
-
01/2006 |
2 | Hormones (Hormone)IBA
06/2015
-
04/2011 |
2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2013
-
10/2010 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011
-
03/2011 |
2 | Triglycerides (Triacylglycerol)IBA
10/2010
-
02/2009 |
2 | Biological ProductsIBA
06/2010
-
11/2005 |
2 | EnzymesIBA
05/2008
-
04/2008 |
2 | ImmunosorbentsIBA
05/2008
-
04/2008 |
2 | LigandsIBA
06/2006
-
11/2005 |
2 | PPAR gammaIBA
06/2006
-
03/2003 |
2 | Paclitaxel (Taxol)FDA LinkGeneric
03/2006
-
11/2005 |
2 | Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2006
-
11/2005 |
2 | Proteins (Proteins, Gene)FDA Link
01/2006
-
11/2005 |
2 | Androgen Receptors (Androgen Receptor)IBA
11/2005
-
11/2005 |
2 | AndrogensIBA
11/2005
-
11/2005 |
1 | Cetuximab (Erbitux)FDA Link
10/2020 |
1 | Capecitabine (Xeloda)FDA Link
06/2015 |
1 | Lapatinib (GW572016)FDA Link
06/2015 |
1 | Therapeutic UsesIBA
09/2013 |
1 | bis(2- ((4- ((4'- (2- hydroxyethoxy)- 2'- methyl(1,1'- biphenyl)- 3- yl)methoxy)phenyl)methyl)- 3,5- dioxo- 1,2,4- oxadiazolidine)IBA
09/2013 |
1 | Leucine (L-Leucine)FDA Link
01/2012 |
1 | ThymidineIBA
01/2012 |
1 | IGF Type 1 Receptor (IGF 1 Receptor)IBA
04/2011 |
1 | Insulin-Like Growth Factor I (IGF-1)IBA
04/2011 |
1 | Insulin-Like PeptidesIBA
04/2011 |
1 | Sitagliptin Phosphate (Januvia)FDA Link
03/2011 |
1 | Rosiglitazone (Avandia)FDA Link
03/2011 |
1 | SecretagoguesIBA
03/2011 |
1 | 2- (4- bromophenyl)- 6- methyl- N- (2- (1- oxidopyridin- 3- yl)ethyl)pyrimidin- 4- amineIBA
11/2010 |
1 | Glyburide (Glibenclamide)FDA LinkGeneric
11/2010 |
1 | 2- cyclopentyl- N- (2,4- dichloro- 3- ((isoquinolin- 5- yloxy)methyl)phenyl)- N- methylacetamideIBA
10/2010 |
1 | AS 1907417IBA
10/2010 |
1 | 2- (2- (4- bromophenyl)- 6- methylpyrimidin- 4- yl)aminoethanolIBA
09/2010 |
1 | HMGB ProteinsIBA
06/2010 |
1 | CytokinesIBA
06/2010 |
1 | Neutralizing AntibodiesIBA
06/2010 |
1 | Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2009 |
1 | Fatty Acids (Saturated Fatty Acids)IBA
02/2009 |
1 | LipidsIBA
02/2009 |
1 | CholesterolIBA
02/2009 |
1 | Hemoglobin AIBA
02/2009 |
1 | Glucagon-Like Peptide 1 (GLP 1)IBA
01/2009 |
1 | Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
01/2009 |
1 | Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
01/2009 |